Clinical Trials
7 trialsNCT07143513 2026-04-07
Real World Evaluation of Sotorasib Among Chinese Non-Small Cell Lung Cancer Patients
Amgen
Completed
NCT06333678 2026-01-29
A Study Comparing Sotorasib With Durvalumab in People With Non-Small Cell Lung Cancer (NSCLC)
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT05054725 2026-01-06
Combination Study of RMC-4630 and Sotorasib for NSCLC Subjects With KRASG12C Mutation After Failure of Prior Standard Therapies
Revolution Medicines, Inc.
Phase 2 Completed
NCT04933695 2025-10-22
CodeBreaK201
Amgen
Phase 2 Completed
NCT04720976 2025-04-11
JAB-3312 Based Combination Therapy in Adult Patients With Advanced Solid Tumors
Allist Pharmaceuticals, Inc.
Phase 1/2 Completed
NCT06314763 2024-04-30
ROSIE
Radboud University Medical Center
Phase 4 Completed
NCT04959981 2023-07-25
HERKULES-2
Erasca, Inc.
Phase 1 Completed